You are here
OAB Symptom Quiz
OAB Symptom Quiz*
IMPORTANT SAFETY INFORMATION
If you have certain stomach problems, glaucoma, or cannot empty your bladder, you should not take TOVIAZ® (fesoterodine fumarate).
TOVIAZ may cause allergic reactions that may be serious. If you experience swelling of the face, lips, throat, or tongue, stop taking TOVIAZ and get emergency medical help right away.
Medicines like TOVIAZ can cause blurred vision, dizziness, drowsiness, and decreased sweating. Do not drive, operate machinery, or do unsafe tasks until you know how TOVIAZ affects you. Use caution in hot environments. Drinking alcohol while taking medicines such as TOVIAZ may cause increased drowsiness.
The most common side effects are dry mouth and constipation.
TOVIAZ has benefits and risks. There may be other options. To learn more about TOVIAZ, please see the Full Prescribing Information and Patient Information.
INDICATION
TOVIAZ® (fesoterodine fumarate) treats the symptoms of overactive bladder (leaks, strong sudden urges to go, going too often).
Patients should always ask their doctors for medical advice about adverse events.
You may report an adverse event related to Pfizer products by calling 1-800-438-1985 (US only). If you prefer, you may contact the US Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as MedWatch where healthcare professionals and consumers can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit MedWatch or call 1-800-FDA-1088.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.
January 2015 FSD695503-01
Copyright © 2015 Pfizer Inc. All rights reserved. Pfizer, PO Box 29387, Mission, KS 66201